Image-Based Simulations
Model drug release, permeability, and more using real or synthesized structures from 2D or 3D images.
Predictive Models from Real Data
Simulations shouldn’t be confined to high-performance desktops or isolated workflows. I2S brings predictive modeling to the cloud, enabling faster, more scalable, and collaborative computation across teams. Our platform combines real-world imaging with high-throughput virtual experimentation, eliminating the need for manual geometry design. Whether you're exploring drug release, permeability, or structural failure, simulations can now be run directly from experimental data.
Image-Based Simulations
DigiM I2S simulations operate on a voxel-resolved 3D images, eliminating the need for mesh generation or structural simplification techniques. This approach enables fast and accurate calculations of material properties such as phase permeability, mercury intrusion (MICP), material elasticity, conductivity, and more. Simulations utilizing real image data helps to ensure representativeness and provides a clearer idea of how microstructural properties are impacting performance.
Long-Acting Acceleration
For pharmaceutical scientists working in long-acting spaces such as injectables and implants, in-vitro lab testing can be slow and expensive. digiM offers a suite of simulations tailored to simulating in-vitro release of these products using 3D images as inputs. This technique has been applied extensivley to implants, microspheres and intrauterine systems helping researchers speed up formulation and manufacturing optimization.
digiM Simulation Ecosystem
While I2S includes simulations for microstructural properties, fluid flow, and in-vitro drug release simulations, Dissolab expands on these capabilities with exploratory formulation specific dissolution modeling. I2S and DissoLab feature seamless connections enable use of images across the 2 simulation platforms, enabling easy access for any simulations of interest.
For more exploratory work GAN Structure Synthesis is a key enabling technology supporting I2S and DissoLab simulations, allowing generation of new microstructures with controlled conditions such as size distribution or volume fractions. Enabling scientists to explore additional parameters spaces without the need for new imaging or manufacturing.
Transform Your Program with Microstructure Science
Get started with a drug product digital twin.
